The New Drug Research Center
The new drug R&D is the core of Beijing Increasepharm Corp., Ltd. Increasepharm integrates the pharmacodynamics and toxicological resources accumulated in the development of new drugs for many years, making full use of its technical strengths in the detection of active ingredients of TCM, chiral drug development, API synthesis, structural modification, new dosage form research, pharmacokinetics biological sample testing, etc. It also establishes a new drug research technology platform, mainly to carry out research and development of Class 1, 2 of new Chemical Drugs, Class 1 to 5 of new Traditional Chinese Medicine.
Modification and application innovation are the main contents of research and development of new drugs. The main research covers:
⑴ New chemical entities and preparation of marketed drugs prepared by structural modification;
⑵ Optical isomers and preparation of marketed drugs prepared by chiral resolution and synthesis;
⑶ New chemical components and preparation prepared by separation from natural drugs and TCM;
⑷ New chemical components and preparation from semi synthesis and total synthesis in the above (3)；
⑸ Prodrugs, drug metabolites and preparation；
⑹ New compound preparation with active ingredients;
⑺ Research and development of new drug delivery routes;
⑻ Research and development of new form, new preparation technology and new dosage form of API.
We have carried out a number of projects.